Katkin Keith's Form 4 filing
Emergent BioSolutions Inc. (EBS) · filed May 28, 2025
- Accession no.
- 0001367644-25-000136
- Filed
- May 28, 2025
- Trade date
- May 23, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $49.4K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Katkin KeithCIK 0001314596 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | Common Stock | SSaleDisposed | −7,844 | $6.30F2 | −$49,417.2 | 86,431 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $6.22 - $6.35. The Company maintains a record of the transactions and copies will be provided upon request.
Referenced by the price of 1 transaction in Table I.